BioSpace News Archive

The American Association of Kidney Patients, the oldest and largest fully independent kidney patient organization in America, announced the opening of the 2021 grant cycle for its AAKP Jenny Kitsen Patient Safety Award.

Project ALS, a non-profit 501(c)3 organization that funds research toward the first meaningful treatments for amyotrophic lateral sclerosis (ALS), announced today that the Food and Drug Administration (FDA) has granted orphan drug designation to prosetin for the treatment of ALS. Prosetin is an oral, brain penetrant MAP4 kinase inhibit

Sickle Cell warrior Tahir “StayFresh” Ali of Atlanta, Ga., visits the hospital twice monthly for blood transfusions to reduce complications from sickle cell disease, and manage his potential risk of organ damage or stroke.

Each year, New Jersey’s 49 birthing hospitals welcome more than 100,000 babies into the world, and they have committed themselves to ensuring the safety and well-being of the mothers and babies in their care.

Apellis Pharmaceuticals, Inc., a global biopharmaceutical company pioneering targeted C3 therapies, announced that the company approved the grant of equity awards to four new employees with grant date of September 1, 2020, as equity inducement awards outside of the company’s 2017 Stock Incentive Plan and material to the employees’ acceptance of employment with the company.

Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases, today announced the closing of its previously announced underwritten public offering of 6,060,606 shares of its common stock, which includes the full exercise of the underwriters’ option to purchase 790,513 additional shares of common stock, at a price to the public of $33.00 per share. The aggregate gro

Amgen (NASDAQ:AMGN) will present at Citi’s 15th Annual Virtual BioPharma Conference at 2:25 p.m. ET on Thursday, Sept. 10, 2020 . Murdo Gordon , executive vice president of Global Commercial Operations at Amgen and Peter H. Griffith , executive vice president and chief financial officer, will present at the conference. Li

Hologic, Inc. announced that the Company will present at these upcoming virtual investor conferences

Havn Life Sciences Inc., is pleased to announce that it has successfully completed its acquisition of HAVN Research Inc., acquiring 100% of the outstanding shares of HAVN Research.

Assembly Biosciences, Inc. announced grants of stock options to five new employees to purchase an aggregate of 86,000 shares of the Company’s common stock with an exercise price of $20.14 per share, the closing price of Assembly’s common stock on September 1, 2020.